The application of molecular topology for ulcerative colitis drug discovery

BELLERA, CAROLINA L.; DI IANNI, MAURICIO E.; TALEVI, ALAN

EXPERT OPINION ON DRUG DISCOVERY

INFORMA HEALTHCARE

Año: 2017 vol. 13 p. 87 - 101

1746-0441

Introduction: Although the therapeutic arsenal against ulcerative colitis has greatly expanded (including the revolutionary advent of biologics), there remain patients who are refractory to current medications while the safety of the available therapeutics could also be improved. Molecular topology provides a theoretic framework for the discovery of new therapeutic agents in a very efficient manner, and its applications in the field of ulcerative colitis have slowly begun to flourish.Areas covered: After discussing the basics of molecular topology, the authors review QSAR models focusing on validated targets for the treatment of ulcerative colitis, entirely or partially based on topological descriptors.Expert opinion: The application of molecular topology to ulcerative colitis drug discovery is still very limited, and many of the existing reports seem to be strictly theoretic, with no experimental validation or practical applications. Interestingly, mechanism-independent models based on phenotypic responseshave recently been reported. Such models are in agreement with the recent interest raised by network pharmacology as a potential solution for complex disorders. These and other similar studies applying molecular topology suggest that some therapeutic categories may present a ?topological pattern? thatgoes beyond a specific mechanism of action.